CAI · Caris Life Sciences, Inc. · Proposed Sales
$17.58
-0.96 (-5.18%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$5.04B
Shares
286.78M
Volume · Nov 20
4.57M
Avg daily vol (3M)
4.64M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-09-22 | JOHN RUSSEL DENTON | Officer | 7,500 | 2026-09-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-17 | BRIAN J BRILLE | Officer, Director | 400,000 | 2026-09-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-04 | DAVID SPETZLER | Officer | 119,212 | 2026-09-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-03 | DAVID SPETZLER | Officer | 478,000 | 2026-09-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-24 | GEORGE H POSTE REVOCABLE TRUST | Former Affiliate | 100,000 | 2026-08-24 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-07 | GEORGE H POSTE | Director | 30,000 | 2026-08-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-03 | GEORGE H POSTE | Director | 20,000 | 2026-08-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-11 | LUKE POWER | Officer | 62,250 | 2025-12-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–8 of 8 filings
Key facts
CIK
2019410
CUSIP
142152107
13F (30d)
312 filings
296 filers
Visit website
Investor relations